Forbes June 18, 2024
Katherine Hignett

Most women experience a hormone imbalance at some stage in their life, and the consequences can be serious. Understanding sex hormones is crucial for fertility care, menopause care and the treatment of conditions like polycystic ovary syndrome.

At the moment, women typically take blood tests to monitor their hormones, providing a snapshot of data.

But a U.K. start-up launched through the University of Southampton’s Future Worlds accelerator program wants to make this information available 24/7.

Founded by optoelectronics researcher Stefan-Tudor Ilie and business graduate Mariajosé Argote, POMHealth is developing a prototype for a real-time continuous hormone monitor. Fertility is their first target.

Getting the timing right for egg retrieval and embryo implantation is “critical” for in vitro fertilization, Argote tells...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Physician, Provider
Social epidemics and the role of physicians
ChatGPT outperformed doctors again? Pitfalls of reporting AI progress
Expert Insights on How Utilization Management Drives Physician Burnout
Shaping the Future of Cardiology: Key Takeaways From AHA 2024
109 hospitals receiving new Medicare-backed residency slots

Share This Article